Servier at ASH meeting to present new data in hematology research
All the news from Servier Group
Primary Sjögren’s syndrome: completion of patient enrollment in Phase 2a clinical trial
Spartners: Biotech start-up welcome to apply!
Servier and HealthTech For Care, a shared commitment to accelerate therapeutic innovation
Servier unveils its 2030 ambition and reveals a new visual identity
Servier reveals a new visual identity
World Heart Day: Servier partner of the World Heart Federation campaign!
Parkinson: Servier exercises the exclusive licensing option on collaborative program with Oncodesign Precision Medicine
Servier collaborates in the treatment of pancreatic cancer